Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1411-1420 of 1,433) with videos related to

Pageof 144
Sort By:
The Lancet. Oncology|August 1, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trialYi-Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerG Villacampa, N M Tung, S Pernas, et al.
Pharmacological Research|April 22, 2026
Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: a target trial emulation using the Italian VALORE distributed database networkAndrea Spini, Luca L'Abbate, Ylenia Ingrasciotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Cancers|June 2, 2021
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast CancerHesham Elghazaly, Hope S Rugo, Hamdy A Azim, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patientsP Fava, C Astrua, A Chiarugi, et al.
Clinical and Experimental Dermatology|July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo NodularisGianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Cancer|July 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendationsHesham Elghazaly, Hamdy A Azim, Hope S Rugo, et al.
Italian Journal of Dermatology and Venereology|May 8, 2023
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter studyPaolo Romita, Carlo A Maronese, Aurora DE Marco, et al.
Pageof 144

Showing results (1411-1420 of 1,433) with videos related to

Sort By:
Pageof 144
The Lancet. Oncology|August 1, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trialYi-Long Wu, Valentina Guarneri, Pei Jye Voon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerG Villacampa, N M Tung, S Pernas, et al.
Pharmacological Research|April 22, 2026
Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: a target trial emulation using the Italian VALORE distributed database networkAndrea Spini, Luca L'Abbate, Ylenia Ingrasciotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Cancers|June 2, 2021
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast CancerHesham Elghazaly, Hope S Rugo, Hamdy A Azim, et al.
Dermatology (Basel, Switzerland)|February 10, 2015
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patientsP Fava, C Astrua, A Chiarugi, et al.
Clinical and Experimental Dermatology|July 15, 2025
Therapeutic Outcomes Across JAK Inhibitors in Prurigo NodularisGianluca Avallone, Andrea Bombelli, Luca Valtellini, et al.
Cancer|July 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendationsHesham Elghazaly, Hamdy A Azim, Hope S Rugo, et al.
Italian Journal of Dermatology and Venereology|May 8, 2023
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter studyPaolo Romita, Carlo A Maronese, Aurora DE Marco, et al.
Pageof 144